CO-VELOCITY-GLOBAL
2.9.2020 07:04:13 CEST | Business Wire | Press release
Velocity Global , the leading provider of global expansion solutions, has selected Amsterdam, Netherlands, as the location for its European headquarters. The Denver-based company appointed Sander Poos as managing director of Europe based in Amsterdam.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200901006149/en/
As an International PEO, Velocity Global serves as an Employer of Record for supported employees in countries where clients have not set up a legal entity, enabling companies to compliantly expand internationally in a matter of weeks, and reduce their expansion costs.
“The number of clients expanding in Europe more than doubled this year compared to the same period in 2019,” said Velocity Global founder and CEO Ben Wright. “Even amidst a global pandemic, our growing clients also doubled the number of supported employees onboarded in Europe this year compared to the same period last year. Europe is critically important for both Velocity Global and our clients.”
The uptick in volume supports findings in Velocity Global’s 2020 State of Global Expansion™ report that 41 percent of tech companies in the U.S. and the UK targeted Europe as the most promising market to grow their customer base.
Amsterdam emerged as the natural choice for Velocity Global’s European headquarters as a business-friendly, culturally attractive city for international commerce. The city is geographically adjacent to key markets like Germany, France, and the United Kingdom. This year, in the final months of the Brexit transition, the European Union received approximately 80 percent of the European growth among Velocity Global clients, while the UK remains the top individual country destination.
Velocity Global established its Amsterdam presence in 2018, and now employs more than 30 team members in Europe serving in corporate and client-facing functions including client experience, employee support, operations, compliance, sales, finance, human resources, and legal.
Sander Poos leads Velocity Global’s team throughout Europe, reporting to Chief Operating Officer José Montero. He adds 25 years of experience in sales and operations in the human resources and software-as-a-service (SaaS) sectors. Poos most recently served as managing director of Benelux for Indeed.com, supporting operations in Amsterdam and Brussels as well as Dublin, Ireland. Previously he held leadership positions for companies including Xerox, Adecco, Monster.com, and Telegraaf Media Group.
“Sander brings a breadth of experience in successfully building people-focused business solutions across Europe,” said Montero. “His leadership balances revenue operations with industry-leading customer experience platforms putting people at the heart of his strategy.”
“New supported employees in Europe represent close to half of our global onboardings this year, a 40 percent increase over the first eight months of 2019,” said Poos. “I am excited to lead European growth for Velocity Global and our clients.”
The company's European team supports 19 languages from Europe, the Middle East, Africa, and Asia, contributing to the 36 languages supported worldwide by Velocity Global. Velocity Global has 250 employees located in 14 countries serving thousands of supported employees for clients in over 100 countries.
ABOUT VELOCITY GLOBAL
Velocity Global is the leading provider of global employment solutions that has reinvented the way companies expand overseas. With unrivaled expertise in over 185 countries, Velocity Global delivers end-to-end services and best-in-class support to help companies confidently navigate the entire lifecycle of international business. To ensure a compliant, efficient, and flexible international expansion, Velocity Global provides a comprehensive suite of global services that includes International PEO, Entity Setup and Support, Global Talent Acquisition, Immigration, and Consulting.
ABOUT SANDER POOS
Sander leads Velocity Global’s European team, responsible for the company’s business activities in the region, including all operations functions, customer experience, service delivery, and partner network alignment. He is a Dutch native based at the company’s European regional headquarters in Amsterdam.
Sander applies 25 years of experience in sales and operations in the human resources and software-as-a-service (SaaS) sectors. He most recently served as managing director of Benelux for Indeed.com, supporting operations in Amsterdam and Brussels as well as Dublin, Ireland. Previously, Sander held leadership positions for companies including Xerox, Adecco, Monster.com, and Telegraaf Media Group.
He received dual university degrees in Labor Market Politics and Personnel Policy, and Catholic Teaching from HAS Den Bosch University Holland, and an MBA from the Imperial College Business School in London. In his free time, he enjoys spending time with his family and playing tennis, and serves on the Board of the Dutch Tennis Association.
See biographies for Velocity Global leaders here .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200901006149/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
